Follow
Maria João Gomes
Maria João Gomes
BIAL
Verified email at bial.com
Title
Cited by
Cited by
Year
Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies
MJ Gomes, S Martins, D Ferreira, MA Segundo, S Reis
International Journal of Nanomedicine 9 (1), 1231-1242, 2014
1502014
Thiolation and cell-penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, ...
Advanced Functional Materials 26 (20), 3405-3416, 2016
1052016
Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
MJ Gomes, J das Neves, B Sarmento
International Journal of Nanomedicine 9 (1), 1757-1769, 2014
792014
Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
C Martins, F Araújo, MJ Gomes, C Fernandes, R Nunes, W Li, HA Santos, ...
European Journal of Pharmaceutics and Biopharmaceutics 138, 111-124, 2019
712019
In vivo dual-delivery of glucagon like peptide -1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
F Araújo, N Shrestha, MJ Gomes, B Herranz-Blanco, D Liu, JJ Hirvonen, ...
Nanoscale 8 (20), 10706-10713, 2016
662016
Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at blood-brain barrier
MJ Gomes, PJ Kennedy, S Martins, B Sarmento
Nanomedicine (London) 12 (12), 2017
652017
Tailoring lipid and polymeric nanoparticles as siRNA carriers towards the blood-brain barrier – from targeting to safe administration
MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento
Journal of Neuroimmune Pharmacology 12 (1), 107-119, 2017
552017
Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, M Airavaara, ...
Journal of Controlled Release 232, 113-119, 2016
532016
siRNA as a tool to improve the treatment of brain diseases: mechanism, targets and delivery
MJ Gomes, S Martins, B Sarmento
Ageing Research Reviews 21, 43-54, 2015
532015
Development of a PEGylated-based platform for efficient delivery of dietary antioxidants across the blood–brain barrier
C Fernandes, M Pinto, C Martins, MJ Gomes, B Sarmento, PJ Oliveira, ...
Bioconjugate Chemistry 29 (5), 1677-1689, 2018
322018
Cell-based in vitro models for studying blood-brain barrier (BBB) permeability
MJ Gomes, B Mendes, S Martins, B Sarmento
Concepts and models for drug permeability studies: cell and tissue based in …, 2016
242016
A new approach for a blood-brain barrier model based on phospholipid vesicles: membrane development and siRNA-loaded nanoparticles permeability
MJ Gomes, J Dreier, J Brewer, S Martins, M Brandl, B Sarmento
Journal of Membrane Science 503, 8-15, 2016
142016
Nanoparticle functionalization for brain targeting drug delivery and diagnostic
MJ Gomes, B Mendes, S Martins, B Sarmento
Handbook of nanoparticles: synthesis, functionalization and surface …, 2016
72016
Lipid nanoparticles for topical and transdermal application for alopecia treatment
MJ Gomes
Faculty of Engineering, University of Porto, Portugal, 2013
32013
Modulation of drug efflux at the blood-brain barrier through targeted siRNA delivery via nanoparticles
MJBT Gomes
PQDT-Global, 2017
2017
Multifunctional tailorable composite system as a dual peptide-drug delivery system
F Araújo, N Shrestha, MJ Gomes, D Liu, B Herranz-Blanco, J Hirvonen, ...
Nanoparticles developed as siRNA carriers towards the blood-brain barrier: from targeting to safe administration
MJ Gomes, C Fernandes, S Martins, F Borges, B Sarmento
The system can't perform the operation now. Try again later.
Articles 1–17